AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing proprietary nebulized combination therapies for chronic respiratory diseases, announced the successful closing of a $21 million Series A financing. The funding round was led by Avalon BioVentures, with additional participation…
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration with the University of British Columbia (UBC). This partnership aims to accelerate the discovery and development of novel antibody…
RevBio, Inc., a developer of regenerative biomaterials for bone repair, announced it has received a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), a division of the National Institutes of Health…
Owlstone Medical, the global leader in Breath Biopsy® technology for early disease detection and precision medicine, announced it has been awarded up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to advance the Platform Optimizing SynBio…
NanoPhoria Bioscience, a next-generation biotech company pioneering precision nanomedicine for cardiovascular and chronic diseases, today announced the first close of its €83.5 million Series A financing round. The round was co-led by XGEN Venture, Sofinnova Partners, and CDP Venture Capital,…
Bruker Corporation today announced the receipt of multiple new orders for its advanced Nuclear Magnetic Resonance (NMR) instrumentation from three leading U.S. research institutions — the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University. Supported…
Kihealth Inc., a precision diagnostics company advancing early disease detection, has announced the successful close of its $5 million oversubscribed seed round, signaling strong investor confidence in its pioneering approach to metabolic health and chronic disease prevention. The funding will…
CTMC, a joint venture between Resilience and The University of Texas MD Anderson Cancer Center, has announced a strategic collaboration with Einstein Hospital Israelita in São Paulo, Brazil, to accelerate the development, manufacturing, and adoption of advanced cell therapies across…
Cartography Biosciences, Inc., a biotechnology company pioneering next-generation T-cell–engaging bispecific and multispecific antibody therapeutics, announced the successful close of a $67 million Series B financing round. The new capital will be used to advance the company’s lead program, CBI-1214, into…
Monash University, Australia’s largest university and one of the world’s top 50 research institutions, has announced the launch of the Monash Boston Hub, a new strategic base designed to strengthen the university’s collaborations with North American and European biotechnology and…